Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pharmacokinetics of piperacillin + tazobactam during continuous venovenous hemodiafiltration in septic oligo-anuric ICU patients
2008-000088-40Phase 4Active
- Sponsor
- Centre hospitalier universitaire de Toulouse
- Start
- May 2008
- Modality
- Small Molecules, Irreversible Covalent Inhibitors → Covalent Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of piperacillin and tazobactam in sepsis and bacterial disease, sponsored by Centre hospitalier universitaire de Toulouse. Started May 2008; status: active.
02
Drugs
piperacillintazobactam
03
Conditions
sepsisbacterial disease
Beyond the preview
Go deeper on 2008-000088-40.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-000088-40.